south africa plans aids vaccine trial johannesburg south africa south africa burdened with one of the worlds major hiv aids epidemics unveiled plans for its biggest aids vaccine trial the government backed south african aids vaccine initiative said the trial will be conducted on hiv negative people from to years old it will test whether the mrkad hiv vaccine developed by merck &amp co either prevents hiv infection or lowers hiv levels in those who become infected it will also measure the effectiveness of the drug on the c strain of hiv prevalent in south africa whose population of million has an hiv infection rate of around one in nine 
